GlaxoSmithKline, CureVac vaccine targeting variants shows promise
GlaxoSmithKline and its partner CureVac have seen promising test results for its “second-generation” vaccine which targets Covid-19 and variants in one shot.
GSK and CureVac teamed up in February in ...